RecruitingNCT06372444

Mechanisms of Acute Kidney Injury in Severe Infections


Sponsor

Uppsala University Hospital

Enrollment

15 participants

Start Date

May 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Renal perfusion and neutrophil-mediated inflammation will be assessed in the kidney in sepsis patients with acute kidney injury using positron emission tomography. For marked water will be used for renal perfusion and a newly developed PET tracer molecule (11C-GW457427) with specific binding to neutrophil elastase which provides a measure of the amount of infiltrating neutrophils in the renal parenchyma for inflammation. The study is performed in a PET-CT camera where anatomical imaging takes place at the same time as the PET examinations.


Eligibility

Min Age: 30 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Positron emission tomography (PET) for people with aki - acute kidney injury, positron-emission tomography(pet), and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 30 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONPositron emission tomography (PET)

Assessment of blood flow with marked water and assessment of neutrophil presence with neutrophil elastase tracer + CT


Locations(1)

Uppsala university hospital

Uppsala, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06372444


Related Trials